Bryan Laulicht is an accomplished executive in the biotechnology and pharmaceuticals industry, known for co-founding and leading several innovative companies. Bryan served as CEO, President, and Co-founder of Perosphere Pharmaceuticals from October 2017 to January 2019, prior to its acquisition by AMAG Pharmaceuticals, where Bryan held the role of Senior Vice President of Early Development until July 2019. Bryan also co-founded Perosphere Inc., serving as Senior Executive VP Research from July 2011 to October 2017. As CEO and Co-founder of Lansdowne Labs in June 2023, Bryan demonstrated leadership in the startup arena. Currently, Bryan is the Expert-in-Residence at Digitalis Commons, advising on early-stage health technologies and program translations for ARPA-H. Educational credentials include a BA in Biophysics from Columbia University, a PhD in Medical Science from Brown University, and a Postdoctoral fellowship at MIT in Health Sciences and Technology. Bryan's significant contributions to the field have been recognized through various leadership roles, emphasizing innovation and development in health solutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices